Your browser doesn't support javascript.
loading
Achieving opioid-free discharge following robotic thoracic surgery: A single-institution experience.
Gross, Daniel J; Alnajar, Ahmed; Villamizar, Nestor R; Nguyen, Dao M.
Afiliación
  • Gross DJ; Division of Thoracic Surgery, The DeWitt Daughtry Department of Surgery, The University of Miami, Miami, Fla.
  • Alnajar A; Division of Thoracic Surgery, The DeWitt Daughtry Department of Surgery, The University of Miami, Miami, Fla.
  • Villamizar NR; Division of Thoracic Surgery, The DeWitt Daughtry Department of Surgery, The University of Miami, Miami, Fla.
  • Nguyen DM; Division of Thoracic Surgery, The DeWitt Daughtry Department of Surgery, The University of Miami, Miami, Fla.
JTCVS Open ; 15: 508-519, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37808010
ABSTRACT

Objectives:

Enhanced recovery after thoracic surgery (ERATS) protocols use a combination of analgesics for pain control and have been associated with decreased opioid requirements. We investigated the impact of continual ERATS refinement on the incidence of opioid-free discharge.

Methods:

We retrospectively analyzed our prospectively maintained institutional database for elective, opioid-naive robotic thoracoscopic procedures. Demographics, operative outcomes, postoperative opioid dispensed (morphine milligram equivalent), and opioid discharge status were collected. Our primary outcome of interest was factors associated with opioid-free discharge; our secondary objective was to determine the incidence of new persistent opioid users.

Results:

In total, 466 patients from our optimized ERATS protocol were included; 309 (66%) were discharged without opioids. However, 34 (11%) of patients discharged without opioids required a prescription postdischarge. Conversely, 7 of 157 patients (11%), never filled their opioid prescriptions given at discharge. Factors associated with opioid-free discharges were nonanatomic resections, mediastinal procedures, minimal pain, and lack of opioid usage on the day of discharge. More importantly, 3.2% of opioid-free discharge patients became new persistent opioid users versus 10.8% of patients filling opioid prescriptions after discharges (P = .0013). Finally, only 2.3% of opioid-naive patients of the entire cohort became chronic opioid users; there was no difference in the incidence of chronic use by opioid discharge status.

Conclusions:

Optimized opioid-sparing ERATS protocols are highly effective in reducing opioid prescription on the day of discharge. We observed a very low rate of new persistent or chronic opioid use in our cohort, further highlighting the role ERATS protocols in combating the opioid epidemic.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: JTCVS Open Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: JTCVS Open Año: 2023 Tipo del documento: Article